JP2006151834A - Skin cosmetic - Google Patents

Skin cosmetic Download PDF

Info

Publication number
JP2006151834A
JP2006151834A JP2004341305A JP2004341305A JP2006151834A JP 2006151834 A JP2006151834 A JP 2006151834A JP 2004341305 A JP2004341305 A JP 2004341305A JP 2004341305 A JP2004341305 A JP 2004341305A JP 2006151834 A JP2006151834 A JP 2006151834A
Authority
JP
Japan
Prior art keywords
skin
weight
effect
meth
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004341305A
Other languages
Japanese (ja)
Other versions
JP5311704B2 (en
Inventor
Misaki Ishida
実咲 石田
Ki-Ho Kim
キー・ホー・キム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOLAND Ltd
TOA KASEI KK
NOF Corp
Original Assignee
BIOLAND Ltd
TOA KASEI KK
NOF Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOLAND Ltd, TOA KASEI KK, NOF Corp filed Critical BIOLAND Ltd
Priority to JP2004341305A priority Critical patent/JP5311704B2/en
Priority to KR1020050107423A priority patent/KR100698356B1/en
Publication of JP2006151834A publication Critical patent/JP2006151834A/en
Application granted granted Critical
Publication of JP5311704B2 publication Critical patent/JP5311704B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a skin cosmetic giving light feeling in use, quickly fitting to the skin, free from stickiness after use, keeping the moisturizing effect for a long period, having excellent effect for improving roughened skin and suppressing wrinkles, giving springiness to the skin and having excellent time stability. <P>SOLUTION: The skin cosmetic contains (a) a copolymer containing a constitutional unit based on 2-(meth)acryloyloxyethyl phosphorylcholine expressed by formula (I) (R<SP>1</SP>is H or methyl; R<SP>2</SP>, R<SP>3</SP>and R<SP>4</SP>are each a 1-8C alkyl; and n is an integer of 2-4) and a constitutional unit based on an alkyl (meth)acrylate at a molar ratio of 100/0 to 10/90 and total amount of both constitutional units of 60-100 wt.% in the copolymer and (b) an extract of Portulaca oleracea. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は化粧水、乳液、クリーム、パック、ヘアトニック、ファンデーション等の皮膚用の化粧料に関し、さらに詳しくは使用時の感触が軽く素早く肌になじむとともに、使用後もべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れ、肌にはりを与えて経時安定性にも優れる皮膚化粧料に関する。   The present invention relates to skin cosmetics such as skin lotions, emulsions, creams, packs, hair tonics, foundations, and the like. More specifically, the skin feels light when used and quickly adapts to the skin. The present invention relates to a skin cosmetic that is excellent in properties, has an effect of improving skin roughness, has an effect of suppressing wrinkles, gives skin elasticity, and has excellent temporal stability.

通常、人の皮膚表面は皮脂膜に覆われていて水分の蒸散が適度に抑制されている。そして、皮膚の水分を適切な範囲に保つことは皮膚の健康の面から見て非常に大切なことであり、水分が不足すると肌荒れ等を生じやすくなる。洗顔や入浴を行うと一時的に皮脂膜が取り除かれてしまい肌の水分が失われやすくなることから化粧水、乳液、クリーム、美容液等の保湿化粧料を使用して水分を補う必要がある。ここで、一般に化粧料には保湿剤としてグリセリン、1,3−ブチレングリコール、ソルビトール等の多価アルコール類やピロリドンカルボン酸塩等が配合されているが、これらの保湿剤は高湿度下における水分保持力には優れているものの低湿度下における水分保持力に難があり、保湿効果の持続性が保てないばかりでなく、場合により皮膚の水分を吸収することから逆に肌荒れを促進させることが知られている。そこで近年、低湿度下での水分保持力の高い保湿成分としてキチン、キトサン及びそれらの誘導体、蛋白加水分解物、ヒアルロン酸等の酸性ムコ多糖類、植物抽出物等様々な高保湿成分が提案されている。しかし、これらの保湿成分を化粧料に配合するとその高い保湿力から不快なべたつきを有するという欠点があった。そこで、高い保湿効果を保持しながらべたつきを改善したものとして、例えば、ムコ多糖類とトレハロースとを組み合わせた特許文献1記載の皮膚外用剤等があるが、いまだ十分にべたつきを抑えることはできておらず、しかも肌へのなじみ性、肌荒れ改善効果、肌にはりを与える効果、しわ抑制効果等に関して十分な性能が得られていなかった。   Usually, the surface of human skin is covered with a sebum film, and the transpiration of water is moderately suppressed. Keeping the skin moisture within an appropriate range is very important from the viewpoint of skin health. If the moisture is insufficient, rough skin and the like are likely to occur. If you wash your face or bath, the sebum film will be temporarily removed and it will be easy to lose the moisture of your skin, so it is necessary to supplement the moisture with moisturizing cosmetics such as lotion, milky lotion, cream, and beauty serum. . Here, in general, cosmetics are blended with polyhydric alcohols such as glycerin, 1,3-butylene glycol, sorbitol, pyrrolidone carboxylate, and the like as moisturizers. Although it has excellent holding power, it has difficulty in holding water under low humidity, and it can not only maintain the moisturizing effect, but it also absorbs moisture from the skin in some cases and promotes rough skin. It has been known. Therefore, in recent years, various highly moisturizing ingredients such as chitin, chitosan and their derivatives, protein hydrolysates, acidic mucopolysaccharides such as hyaluronic acid, plant extracts and the like have been proposed as moisturizing ingredients with high moisture retention at low humidity. ing. However, when these moisturizing ingredients are blended in cosmetics, there is a drawback that they have an unpleasant stickiness due to their high moisturizing power. Therefore, as an example of improving the stickiness while maintaining a high moisturizing effect, for example, there is a skin external preparation described in Patent Document 1 in which mucopolysaccharide and trehalose are combined, but the stickiness can still be sufficiently suppressed. In addition, sufficient performance was not obtained with regard to skin conformability, skin roughness improvement effect, skin elasticity effect, wrinkle suppression effect, and the like.

一方、皮膚化粧料の重要な機能として肌荒れ防止及び改善効果が挙げられる。ここで、一般的にこれらの機能を十分に発揮させる為には上記のような保湿剤とともに油分を配合することが有効であり、乳液、クリーム、美容液等の乳化した剤形により使用されることが多い。しかし、油分を使用した製品では使用時ののびが悪くなったりベタツキを生じたりすることが多く、これらを解決することが困難であるという問題があった。そこで、例えば、特許文献2、3では分子内にホスホリルコリン基を有する特定の高分子化合物を使用することで油分の有する閉塞性を補うとともに、ベタツキを抑えた化粧料を提案している。   On the other hand, as an important function of the skin cosmetic, there is an effect of preventing and improving rough skin. Here, in order to fully exhibit these functions, it is effective to blend oil with a moisturizer as described above, and it is used in an emulsified dosage form such as a milky lotion, cream, or cosmetic liquid. There are many cases. However, products using oil often suffer from poor spread and stickiness during use, and there is a problem that it is difficult to solve these problems. Therefore, for example, Patent Documents 2 and 3 propose cosmetics that compensate for the occlusion of an oil component and suppress stickiness by using a specific polymer compound having a phosphorylcholine group in the molecule.

また、化粧品において肌荒れ防止及び改善効果の更なる機能強化を目的として保湿効果の高い成分やビタミン類とともにグリチルリチン酸塩やグリチルレチン酸誘導体、アズレン誘導体等様々な抗炎症剤を配合することも試みられている(特許文献4記載の皮膚化粧料、特許文献5〜7記載の皮膚外用剤)。しかし、良好な使用感を有しつつ十分な肌荒れ改善効果を有する化粧料は得られていないのが現状であり、しかも、加齢や紫外線等に起因するしわの生成を効果的に抑制したり改善したりするとともに肌をなめらかにして、はりとうるおいのある若々しい肌に整えるといった、いわゆる皮膚の老化防止の効果を十分併せ持つ化粧料は得られていなかった。
特開平6−122621号公報 特開平5−70321号公報 特開平6−157269号公報 特開平7−277943号公報 特開平6−32728号公報 特開平8−99858号公報 特開平9−241147号公報
In cosmetics, various anti-inflammatory agents such as glycyrrhizinate, glycyrrhetinic acid derivatives, and azulene derivatives are also tried to be added together with ingredients with high moisturizing effect and vitamins for the purpose of preventing rough skin and enhancing the function. (Skin cosmetics described in Patent Document 4, skin external preparations described in Patent Documents 5 to 7). However, it is the present situation that cosmetics that have a satisfactory feeling of use and have a sufficient rough skin improvement effect have not been obtained, and moreover, wrinkles caused by aging, ultraviolet rays, etc. can be effectively suppressed. Cosmetics having sufficient effects of preventing skin aging, such as improving and smoothing the skin to prepare a youthful skin with moisture and moisture, have not been obtained.
JP-A-6-122621 Japanese Patent Laid-Open No. 5-70321 JP-A-6-157269 Japanese Unexamined Patent Publication No. 7-277743 JP-A-6-32728 JP-A-8-99858 JP-A-9-241147

本発明は化粧水、乳液、クリーム、パック、ヘアトニック、ファンデーション等の皮膚用の化粧料を提供し、さらに詳しくは使用時の感触が軽く素早く肌になじむとともに、使用後もべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れ、肌にはりを与えて経時安定性にも優れた皮膚化粧料を提供することを目的とする。   The present invention provides skin cosmetics such as lotions, emulsions, creams, packs, hair tonics, foundations and the like. More specifically, the skin feels light when used and quickly adapts to the skin. An object of the present invention is to provide a skin cosmetic that is excellent in the persistence of the skin, is excellent in the effect of improving the rough skin, is excellent in the effect of suppressing wrinkles, is applied to the skin, and is excellent in stability with time.

上記課題を解決する為に研究を重ねたところ、特定の水溶性高分子と特定の植物エキスを特定の比率で組み合わせることで目的の皮膚化粧料を得るに至った。   As a result of researches to solve the above-mentioned problems, a target skin cosmetic was obtained by combining a specific water-soluble polymer and a specific plant extract in a specific ratio.

すなわち、本発明は以下の通りである。
(1)(a)成分として、式(I)で示される2−(メタ)アクリロイルオキシエチルホスホリルコリンに基づく構成単位と、(メタ)アクリル酸アルキルエステルに基づく構成単位とを100/0〜10/90のモル比で含み、両構成単位の合計重量%が60〜100%である共重合体0.005〜10重量%、(b)成分として、スベリヒユ抽出エキスを乾燥重量として0.0005〜2重量%含有することを特徴とする皮膚化粧料。
That is, the present invention is as follows.
(1) As the component (a), a structural unit based on 2- (meth) acryloyloxyethyl phosphorylcholine represented by the formula (I) and a structural unit based on an alkyl (meth) acrylate ester are 100/0 to 10 / 0.005 to 10% by weight of a copolymer comprising 90 to 100% of the total weight% of both constitutional units, and 0.0005 to 2 in terms of dry weight as a component (b) A skin cosmetic characterized by containing% by weight.

Figure 2006151834
Figure 2006151834

(式中R1は水素原子またはメチル基を、R、R及びRはそれぞれ炭素数1〜8のアルキル基、nは2〜4の整数を示す。) (Wherein R 1 represents a hydrogen atom or a methyl group, R 2 , R 3 and R 4 each represents an alkyl group having 1 to 8 carbon atoms, and n represents an integer of 2 to 4)

(2)さらに、(c)成分として、抗炎症剤を0.001〜10重量%含有することを特徴とする上記(1)記載の皮膚化粧料。 (2) The skin cosmetic according to (1) above, further comprising 0.001 to 10% by weight of an anti-inflammatory agent as the component (c).

本発明によれば、式(I)で示される2−(メタ)アクリロイルオキシエチルホスホリルコリンに基づく構成単位と(メタ)アクリル酸アルキルエステルに基づく構成単位とを含有するポリマーと、スベリヒユ抽出エキスとを特定の比率で組み合わせることにより、使用時の感触が軽く素早く肌になじむとともに、使用後もべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れ、肌にはりを与えて経時安定性にも優れた皮膚化粧料を提供することが可能である。   According to the present invention, a polymer containing a structural unit based on 2- (meth) acryloyloxyethyl phosphorylcholine represented by formula (I) and a structural unit based on a (meth) acrylic acid alkyl ester; By combining at a specific ratio, it feels light and feels comfortable when used, and is non-sticky after use, has excellent moisturizing effect, excellent skin roughness improvement effect, wrinkle suppression effect, and gives skin firmness It is possible to provide a skin cosmetic excellent in stability over time.

本発明に用いられる(a)成分のポリマーは、式(I)で示される2−(メタ)アクリロイルオキシエチルホスホリルコリン(PC)に基づく構成単位と(メタ)アクリル酸アルキルエステルに基づく構成単位とを100/0〜10/90のモル比で含有し、好ましくは100/0〜30/70、更に好ましくは95/5〜50/50のモル比で含有するポリマーである。10/90より小さいと肌荒れ防止効果が弱くなる。   The polymer of component (a) used in the present invention comprises a structural unit based on 2- (meth) acryloyloxyethyl phosphorylcholine (PC) represented by formula (I) and a structural unit based on (meth) acrylic acid alkyl ester. The polymer is contained in a molar ratio of 100/0 to 10/90, preferably 100/0 to 30/70, and more preferably 95/5 to 50/50. If it is less than 10/90, the effect of preventing rough skin is weakened.

そして、該ポリマー中のPCおよび(メタ)アクリル酸アルキルエステルの両構成単位の合計重量%は、通常、60〜100%であり、好ましくは70〜100%、更に好ましくは80〜100%である。60%未満では十分な保湿効果の持続性や肌荒れ防止効果が得られない。ここで、ポリマー中のPCと(メタ)アクリル酸アルキルエステルとを併せた量が100重量%でない場合における、PC、(メタ)アクリル酸アルキルエステル以外の成分としては、付加重合可能な二重結合を有する化合物であり、例えば、エチレン、プロピレン、ブテン、イソブテン、スチレン等のオレフィン性炭化水素およびそれらの異性化オレフィン、多量化オレフィン、またはこれらに各種誘導体を導入したオレフィン性化合物;アクリル酸、メタクリル酸、ビニル酢酸、イタコン酸、クロトン酸、マレイン酸、フマル酸等のエチレン性不飽和カルボン酸およびそれらの多量体、無水物、炭素数1〜6の1価アルコール以外のアルコールとのエステル、またはこれらにカルボニル基、アミノ基、シアノ基、ニトリル基などを導入したエチレン性不飽和カルボン酸誘導体;ビニルアルコールおよびこれと各種カルボン酸とのエステル、各種アルコールとのエーテル、またはこれらにカルボニル基、アミノ基、シアノ基、ニトリル基などを導入したエチレン性不飽和カルボン酸誘導体、ビニルアルコールおよびこれらと各種カルボン酸とのエステル、各種アルコールとのエーテル、またはこれらにカルボニル基、アミノ基、シアノ基、ニトリル基などを導入したビニルアルコール誘導体などが挙げられる。   And the total weight% of both structural units of PC and (meth) acrylic-acid alkylester in this polymer is 60-100% normally, Preferably it is 70-100%, More preferably, it is 80-100%. . If it is less than 60%, sufficient moisturizing effect persistence and rough skin prevention effect cannot be obtained. Here, in the case where the combined amount of PC and (meth) acrylic acid alkyl ester in the polymer is not 100% by weight, components other than PC and (meth) acrylic acid alkyl ester include addition-polymerizable double bonds. For example, olefinic hydrocarbons such as ethylene, propylene, butene, isobutene, and styrene, and isomerized olefins, multimerized olefins, or olefinic compounds obtained by introducing various derivatives thereof; acrylic acid, methacrylic acid, Acid, vinyl acetic acid, itaconic acid, crotonic acid, maleic acid, fumaric acid and other ethylenically unsaturated carboxylic acids and their multimers, anhydrides, esters with alcohols other than monohydric alcohols having 1 to 6 carbon atoms, or Introduce a carbonyl group, amino group, cyano group, nitrile group, etc. Ethylenically unsaturated carboxylic acid derivatives; vinyl alcohol and esters thereof with various carboxylic acids, ethers with various alcohols, or ethylenically unsaturated carboxylic acids into which a carbonyl group, amino group, cyano group, nitrile group or the like has been introduced Derivatives, vinyl alcohol and esters of these with various carboxylic acids, ethers with various alcohols, or vinyl alcohol derivatives in which a carbonyl group, amino group, cyano group, nitrile group, or the like is introduced.

また、該ポリマーの分子量は10,000〜10,000,000ダルトンが好ましく、更に好ましくは50,000〜5,000,000ダルトンである。   The molecular weight of the polymer is preferably 10,000 to 10,000,000 daltons, more preferably 50,000 to 5,000,000 daltons.

式(I)で示されるPCにおいて、式中、Rは、水素原子又はメチル基である。また、R、RおよびRは、炭素数1〜8のアルキル基であり、例えば、メチル基、エチル基、n−プロピル基、イソプロピル基等が挙げられる。R、RおよびRは同一でも、異なっていてもよい。また、nは、2〜4の整数である。特に好ましいPCは、式中のR、R、RおよびRがメチル基で、nが2の2−メタクリロイルオキシエチルホスホリルコリンである。 In the PC represented by the formula (I), R 1 is a hydrogen atom or a methyl group. R 2 , R 3 and R 4 are each an alkyl group having 1 to 8 carbon atoms, and examples thereof include a methyl group, an ethyl group, an n-propyl group, and an isopropyl group. R 2 , R 3 and R 4 may be the same or different. Moreover, n is an integer of 2-4. Particularly preferred PC is 2-methacryloyloxyethyl phosphorylcholine in which R 1 , R 2 , R 3 and R 4 are methyl groups and n is 2.

(メタ)アクリル酸アルキルエステル(「(メタ)アクリル」はメタクリル又はアクリルを示す。)を構成するアルコール残基(アルキル基)は炭素数1〜6であり、好ましくは炭素数2〜5、更に好ましくは炭素数3〜4である。該(メタ)アクリル酸アルキルエステルの具体例としては、例えば、メタクリル酸メチル、アクリル酸エチル、メタクリル酸エチル、アクリル酸プロピル、メタクリル酸プロピル、アクリル酸イソプロピル、メタクリル酸イソプロピル、アクリル酸n−ブチル等が挙げられる。   The alcohol residue (alkyl group) constituting the (meth) acrylic acid alkyl ester ("(meth) acryl" represents methacryl or acryl) has 1 to 6 carbon atoms, preferably 2 to 5 carbon atoms, and more Preferably it is C3-C4. Specific examples of the (meth) acrylic acid alkyl ester include, for example, methyl methacrylate, ethyl acrylate, ethyl methacrylate, propyl acrylate, propyl methacrylate, isopropyl acrylate, isopropyl methacrylate, n-butyl acrylate, and the like. Is mentioned.

また、本発明で用いられる(b)成分のスベリヒユ抽出エキスとはスベリヒユ科スベリヒユ属の双子葉植物(多くは一年草の多肉で匍匐する草本)の葉、茎、根、花、種子あるいは全草から各種溶媒で抽出したエキスである。具体的には例えば、スベリヒユ(Portulaca oleracea L)、タチスベリヒユ(Portulaca oleracea L. var.sativa DC)、マツバボタン(Portulaca garndiflora Hook)、ヌマハコベ(Montia Fontana L. var.lamprosperma Ledeb)、 ハゼラン(Talinum crassifolium Willd)等があるが、中でもスベリヒユもしくはタチスベリヒユが好ましい。そして、これらの葉、茎、根、花、種子あるいは全草を必要に応じて破砕、又は乾燥処理を行った後に炭化水素、エステル類、ケトン類、エーテル類、ハロゲン化炭化水素類、アルコール類及び水から選ばれる1種または2種以上の溶媒と共に加熱還流あるいは浸漬して抽出することが挙げられ、好ましくは水、エタノール、プロピレングリコール、イソプロピルアルコール、1,3−ブチレングリコール、酢酸エチルの1種または2種以上の溶媒で抽出したものであり、更に好ましくは水または1,3−ブチレングリコールで抽出したものである。尚、本発明でいうスベリヒユ抽出エキスとは抽出溶液そのもの、もしくはその濃縮物をいう。そして、このスベリヒユ科植物の抽出物は特開2003−12446号公報において刺激性成分と併用するとその刺激性が低減されることが示されており、市販のものとしてバイオランド社(Bioland Ltd.)製「POTURACA EXTRACT」等がある。   In addition, (b) component purslane extract used in the present invention is a leaf, stem, root, flower, seed, or whole of a dicotyledonous plant of the genus purslane (generally herb that is succulent with succulents of annual grass). It is an extract extracted from grass with various solvents. Specifically, for example, purslane (Portulaca oleracea L), Tachisubihiyu (Portulaca oleracea L. var. Willd) and the like, but among them, the purslane or the prickly purse are preferred. After these leaves, stems, roots, flowers, seeds or whole plants are crushed or dried as necessary, hydrocarbons, esters, ketones, ethers, halogenated hydrocarbons, alcohols And extraction by heating under reflux or immersion with one or more solvents selected from water, preferably 1 of water, ethanol, propylene glycol, isopropyl alcohol, 1,3-butylene glycol, and ethyl acetate. Extracted with seeds or two or more solvents, more preferably extracted with water or 1,3-butylene glycol. In addition, the purslane extract referred to in the present invention refers to the extraction solution itself or a concentrate thereof. In addition, this extract of the genus Euphorbiaceae is shown in Japanese Patent Application Laid-Open No. 2003-12446 to reduce its irritancy when used in combination with an irritant component, and is commercially available as Bioland Ltd. There is "POTURACA EXTRACT" made by.

一方、本発明に用いられる抗炎症剤としては、例えばグリチルリチン酸およびその誘導体、グリチルレチン酸およびその誘導体、アラントインおよびその誘導体、グアイアズレン、インドメタシン、ケトプロフェン、ピロシキカム、アセトアミノフェン、アスピリン、サリチル酸、ブフェマキサク、スプロフェン、イブプロフェンピコノール、フルルビプロフェン、プラノプロフェン、ジクロフェナクナトリム、サリチル酸ナトリウム、サリチル酸メチル、ベンザダック、フェルビナク、ウフェルナマート、ヒドロコルチゾン、プレドニゾロン、塩酸ジフェンヒドラミン、甘草エキス、プロポリスエキス等が挙げられる。その中でも好ましいものは、グリチルリチン酸およびその誘導体、グリチルレチン酸およびその誘導体、アラントインおよびその誘導体、グアイアズレンから選ばれる1種または2種以上の成分であり、更に好ましいものはグリチルリチン酸およびその誘導体、グリチルレチン酸およびその誘導体、アラントインおよびその誘導体から選ばれる1種または2種以上の成分である。グリチルリチン酸の誘導体としてはグリチルリチン酸ジカリウム、グリチルリチン酸モノカリウム、グリチルリチン酸モノアンモニウム等があり、グリチルレチン酸の誘導体としてはグリチルレチン酸ステアリル、グリチルレチン酸グリチルレチニル、3−サクシニルオキシグリチルレチン酸2ナトリウム等があり、アラントインの誘導体としてはアラントインクロルヒドロキシアルミニウム、アラントインジヒドロキシアルミニウム等がある。   On the other hand, the anti-inflammatory agent used in the present invention includes, for example, glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, allantoin and its derivatives, guaiazulene, indomethacin, ketoprofen, pyrosiquicam, acetaminophen, aspirin, salicylic acid, buphemaxak, suprofen , Ibuprofen piconol, flurbiprofen, pranoprofen, diclofenacnutrim, sodium salicylate, methyl salicylate, benzadac, felbinac, ufernamate, hydrocortisone, prednisolone, diphenhydramine hydrochloride, licorice extract, propolis extract and the like. Among them, preferred are glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, allantoin and its derivatives, one or more components selected from guaiazulene, and more preferred are glycyrrhizic acid and its derivatives, glycyrrhetinic acid And one or more components selected from the derivatives thereof, allantoin and the derivatives thereof. Derivatives of glycyrrhizic acid include dipotassium glycyrrhizinate, monopotassium glycyrrhizinate, monoammonium glycyrrhizinate, and derivatives of glycyrrhetinic acid include stearyl glycyrrhetinate, glycyrrhetinyl glycyrrhetinate, disodium 3-succinyloxyglycyrrhetinate, and allantoin. Examples of the derivatives include allantoinchlorohydroxyaluminum and allantoindihydroxyaluminum.

そして、本発明の(a)成分は組成物全量中に0.005〜10重量%であり、好ましくは0.01〜7重量%であり、更に好ましくは0.01〜5重量%である。0.005重量%未満では保湿効果の持続性、肌荒れ改善効果、しわ抑制効果が弱くなり、10重量%を超えると使用時の感触が重く、使用後のべたつき感が強くなり、経時安定性を欠く場合がある。   And the (a) component of this invention is 0.005-10 weight% in a composition whole quantity, Preferably it is 0.01-7 weight%, More preferably, it is 0.01-5 weight%. If it is less than 0.005% by weight, the durability of the moisturizing effect, the effect of improving rough skin, and the effect of suppressing wrinkles are weakened. If it exceeds 10% by weight, the feel during use is heavy, the stickiness after use becomes strong, and the stability over time is improved. It may be missing.

本発明の(b)成分は組成物全量中に乾燥重量として0.0005〜2重量%、好ましくは0.001〜2重量%、更に好ましくは0.001〜1重量%含まれる。0.0005重量%未満では肌へのなじみ性が悪くなるとともに、肌荒れ改善効果、しわ抑制効果、肌にはりを与える効果が弱くなり、2重量%を超えると安定性が悪くなる。   The component (b) of the present invention is contained in the total amount of the composition by 0.0005 to 2% by weight, preferably 0.001 to 2% by weight, and more preferably 0.001 to 1% by weight. When the amount is less than 0.0005% by weight, the conformability to the skin is deteriorated, and the effect of improving the skin roughness, the effect of suppressing wrinkles and the effect of giving the skin are weakened, and when the amount exceeds 2% by weight, the stability is deteriorated.

ただし、本発明でいう乾燥重量とは、抽出溶媒が揮発性の場合には、通常抽出エキスを105℃で乾燥して溶媒を除去した時の残留物の重量を指し、他方、抽出溶媒が不揮発性の場合には、ガスクロマトグラフィーや高速液体クロマトグラフィー等により溶媒量を定量した値から溶質量を計算値として求め、乾燥重量と見なすこととする。   However, the dry weight as used in the present invention refers to the weight of the residue when the extract is usually dried at 105 ° C. and the solvent is removed when the extract solvent is volatile, while the extract solvent is non-volatile. In the case of sexuality, the dissolved mass is obtained as a calculated value from the value obtained by quantifying the amount of solvent by gas chromatography, high performance liquid chromatography or the like, and is regarded as the dry weight.

また、本発明においては肌荒れ改善効果、しわ抑制効果の更なる向上の為に(c)成分を組成物全量中に0.001〜10重量%含有することが好ましく、更に好ましくは0.01〜5重量%である。0.01重量%未満の場合には添加効果が得られにくい場合があり、10重量%を超えるとべたつきを有したり安定性に問題を生じたりするとともにコスト的に不利である。   Moreover, in this invention, it is preferable to contain 0.001-10 weight% of (c) component in the composition whole quantity for the further improvement of the rough skin improvement effect and a wrinkle suppression effect, More preferably, 0.01- 5% by weight. If the amount is less than 0.01% by weight, the effect of addition may be difficult to obtain. If the amount exceeds 10% by weight, stickiness or a problem in stability is caused, and the cost is disadvantageous.

尚、本発明の皮膚化粧料には、化粧料に常用されている添加剤を本発明の皮膚化粧料の性能を損なわない範囲で配合することも可能である。例えばエタノール、イソプロピルアルコール等の低級アルコール、プロピレングリコール、ジプロピレングリコール、グリセリン、ジグリセリン、1,3−ブチレングリコール、ポリエチレングリコール、ソルビトール、マルチトール、イソマルチトール等の多価アルコール類、乳糖、果糖、ショ糖、マルトース又はその誘導体、トレハロース(α,α−トレハロース、α,β−トレハロース、β,β−トレハロース)又はその誘導体、グリコシルトレハロース又はその誘導体、イソマルトオリゴ糖等の糖類、流動パラフィン、流動イソパラフィン、スクワラン、ワセリン、固形パラフィン等の炭化水素系油、牛脂、豚脂、魚油等の天然油脂類、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸等の脂肪酸類、トリ2−エチルヘキサン酸グリセリル等の合成トリグリセライド、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、パルミチン酸セチル、オレイン酸エチル、オレイン酸オレイル、ミリスチン酸オクチルドデシル等のエステル油、ミツロウ、カルナバロウ等のロウ類、高重合ジメチルポリシロキサン、ポリエーテル変性ジメチルポリシロキサン、アミノ変性ジメチルポリシロキサン等のシリコーン誘導体、セラミド、コレステロール、蛋白誘導体、ラノリン、ラノリン誘導体、レシチン等の油性基剤、石鹸、アシルメチルタウリン塩、アミドエーテル硫酸エステル塩等の陰イオン性界面活性剤、アミドアミノ酸塩、アミドプロピルジメチルアミノ酢酸ベタイン等の両性界面活性剤、ポリオキシエチレンアルキルエーテル、ポリエチレングリコールの脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレン硬化ひまし油、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、グリセリンモノ脂肪酸エステル、アルキルポリグルコシド、アルカノールアミド等の非イオン性界面活性剤、塩化アルキルトリメチルアンモニウム等の陽イオン性界面活性剤、アルキルジメチルアミンオキシド等の半極性界面活性剤、アルギン酸、カルボキシビニルポリマー、カルボキシメチルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース、キサンタンガム、プルラン等の水溶性高分子、ピロリドンカルボン酸塩、クエン酸塩、リンゴ酸塩、食塩等の有機または無機塩類、pH調製剤としての酸及びアルカリ、殺菌剤、キレート剤、抗酸化剤、血行促進剤、紫外線吸収剤、紫外線散乱剤、動植物由来の天然エキス、アスコルビン酸とその誘導体、ルチン、ヘスペリジン、アントシアニン等のフラボノイド類とその誘導体、ビタミン類、アミノ酸類、感光素、色素、顔料及び香料等を配合できる。   In addition, it is also possible to mix | blend the additive normally used for cosmetics with the skin cosmetics of this invention in the range which does not impair the performance of the skin cosmetics of this invention. For example, lower alcohols such as ethanol and isopropyl alcohol, propylene glycol, dipropylene glycol, glycerin, diglycerin, 1,3-butylene glycol, polyhydric alcohols such as polyethylene glycol, sorbitol, maltitol, and isomaltitol, lactose, fructose , Sucrose, maltose or derivatives thereof, trehalose (α, α-trehalose, α, β-trehalose, β, β-trehalose) or derivatives thereof, glycosyl trehalose or derivatives thereof, sugars such as isomaltoligosaccharide, liquid paraffin, fluid Hydrocarbon oils such as isoparaffin, squalane, petrolatum, solid paraffin, natural fats such as beef tallow, lard, fish oil, fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, tri-2-ethyl Synthetic triglycerides such as glyceryl sanate, isopropyl myristate, isopropyl palmitate, cetyl palmitate, ethyl oleate, oleyl oleate, octyldodecyl myristate, waxes such as beeswax and carnauba wax, highly polymerized dimethylpolysiloxane , Silicone derivatives such as polyether-modified dimethylpolysiloxane and amino-modified dimethylpolysiloxane, ceramides, cholesterol, protein derivatives, lanolin, lanolin derivatives, oily bases such as lecithin, soaps, acylmethyl taurine salts, amide ether sulfates, etc. Anionic surfactants, amide amino acid salts, amphoteric surfactants such as amidopropyldimethylaminoacetic acid betaine, polyoxyethylene alkyl ether, polyethylene glycol fat Nonionic surfactants such as acid esters, sorbitan fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene hydrogenated castor oil, polyglycerin fatty acid esters, polyoxyethylene glycerin fatty acid esters, glycerin monofatty acid esters, alkylpolyglucosides, alkanolamides Agents, cationic surfactants such as alkyltrimethylammonium chloride, semipolar surfactants such as alkyldimethylamine oxide, water solubility such as alginic acid, carboxyvinyl polymer, carboxymethylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, xanthan gum, pullulan Polymers, organic or inorganic salts such as pyrrolidone carboxylate, citrate, malate, sodium chloride, acids as pH adjusters And alkalis, bactericides, chelating agents, antioxidants, blood circulation promoters, UV absorbers, UV scattering agents, natural extracts derived from animals and plants, ascorbic acid and its derivatives, flavonoids such as rutin, hesperidin, anthocyanins and their derivatives, Vitamins, amino acids, photosensitizers, dyes, pigments, and fragrances can be blended.

次に実施例によって本発明を更に詳細に説明する。   Next, the present invention will be described in more detail by way of examples.

実施例1〜3及び比較例1、2
表1に示す透明または半透明化粧水である皮膚化粧料を調製し、7つの評価項目について下記評価基準により評価を行なった。但し、共通添加成分として表2に示す5成分を使用した。なお、表1中、各左欄に示される括弧書内の有効分とは、例えば、表の左欄に示されるPCポリマー1等の各成分が使用された場合に、そのうちに含まれる実際に有効な所望の成分(PCポリマー1では、(a)成分)の割合をいい、その重量%は、水溶液中に含まれる(a)、(b)および(c)の各成分の重量%を示している。例えば、実施例1では、中欄に示されるように、(a)成分として、PCポリマー1を1重量%用いているが、(a)成分を含むPCポリマーは、表1の左欄の(有効分:40重量%)により、40重量%の(a)成分を含んでおり、実施例1で実際に用いられる(a)成分は、1×0.4=0.4重量%となる。このような実際に含まれる(a)、(b)または(c)成分は、各欄の括弧書にて示している。
Examples 1 to 3 and Comparative Examples 1 and 2
Skin cosmetics that are transparent or translucent lotions shown in Table 1 were prepared, and seven evaluation items were evaluated according to the following evaluation criteria. However, the five components shown in Table 2 were used as common additive components. In Table 1, the effective amount in parentheses shown in each left column is, for example, when each component such as PC polymer 1 shown in the left column of the table is actually used. It refers to the proportion of effective desired components (in the PC polymer 1, component (a)), and the weight% indicates the weight% of each component (a), (b) and (c) contained in the aqueous solution. ing. For example, in Example 1, as shown in the middle column, 1% by weight of the PC polymer 1 is used as the component (a), but the PC polymer containing the component (a) The effective component is 40% by weight), and 40% by weight of the component (a) is contained. The component (a) actually used in Example 1 is 1 × 0.4 = 0.4% by weight. Such (a), (b) or (c) component actually contained is indicated in parentheses in each column.

結果を表1に示す。   The results are shown in Table 1.

Figure 2006151834
Figure 2006151834

注1;「Lipidure−HM」(日本油脂(株)製)「MPC100重量%の構成で重量平均分子量約8万のポリマー40重量%含有水溶液」
注2;「Lipidure−PMB」(日本油脂(株)製)「MPC80重量%、メタクリル酸ブチル20重量%の構成比で重量平均分子量約60万のポリマー5重量%含有水溶液」
(MPC:2−メタクリロイルオキシエチルホスホリルコリン))
注3;「POTURACA EXTRACT」(バイオランド社製Lot.NMP-L-150603)
注4;「POTURACA EXTRACT」(バイオランド社製Lot.NMP-L-202223)
注5;「グリチリチンK2」(丸善製薬(株))
注6;「アラントイン」(川研ファインケミカル(株))
Note 1: “Lipidure-HM” (manufactured by NOF Corporation) “Aqueous solution containing 40% by weight of polymer having a weight average molecular weight of about 80,000 with MPC of 100% by weight”
Note 2: “Lipidure-PMB” (manufactured by NOF Corporation) “Aqueous solution containing 5% by weight of polymer having a weight average molecular weight of about 600,000 with a composition ratio of 80% by weight of MPC and 20% by weight of butyl methacrylate”
(MPC: 2-methacryloyloxyethyl phosphorylcholine))
Note 3: “POTURACA EXTRACT” (Bioland Lot.NMP-L-150603)
Note 4: “POTURACA EXTRACT” (Bioland Lot.NMP-L-202223)
Note 5: “Glychiritin K2” (Maruzen Pharmaceutical Co., Ltd.)
Note 6: “Allantoin” (Kawaken Fine Chemical Co., Ltd.)

Figure 2006151834
Figure 2006151834

評価項目及び評価基準
(1)使用時の感触
20名の女性(21才〜35才)をパネラーとし、洗顔した後に皮膚化粧料(約2g)を使用した時の感触について下記のように判定し、20名の平均値を求めて、平均値1.5点以上を使用時の感触の軽い化粧料であると評価した。
2点:使用時にべたつきも無く肌へのなじみが良いと感じた場合。
1点:使用時にややべたつきが有ったりやや肌へのなじみが悪いと感じた場合。
0点:使用時にべたつきが有るもしくは肌へのなじみが悪いと感じた場合。
Evaluation Items and Evaluation Criteria (1) Feeling when using 20 panelists (21 to 35 years old) as panelists and determining the feeling when using skin cosmetics (about 2 g) after washing their face as follows The average value of 20 people was obtained, and an average value of 1.5 points or more was evaluated as a light-feeling cosmetic when used.
2 points: When you feel that there is no stickiness during use and that you are familiar with the skin.
1 point: When it is slightly sticky at the time of use, or when it is felt that the familiarity with the skin is poor.
0 point: When stickiness is felt during use or when the skin feels bad.

(2)使用後のべたつき
20名の女性(21才〜35才)をパネラーとし、洗顔した後に皮膚化粧料(約2g)を使用して10分後の肌の感触について下記のように判定し、20名の平均値を求めて、平均値1.5点以上を使用後のべたつきがない化粧料であると評価した。
2点:肌がべたつきが無いと感じた場合。
1点:肌がややべたつくと感じた場合。
0点:肌が非常にべたつくと感じた場合。
(2) Stickiness after use 20 women (21 to 35 years old) are panelists, and after washing their face, using skin cosmetics (about 2g), the skin feel after 10 minutes is determined as follows. The average value of 20 people was obtained, and an average value of 1.5 or more was evaluated as a cosmetic without stickiness after use.
2 points: When the skin feels non-sticky.
1 point: When the skin feels somewhat sticky.
0 points: When the skin feels very sticky.

(3)保湿効果の持続性
20名の女性(21才〜35才)をパネラーとし、洗顔した後に皮膚化粧料(約2g)を使用して2時間後の肌のうるおいについて下記のように判定し、20名の平均値を求めて、平均値1.5点以上を保湿効果の持続性の良好な化粧料であると評価した。
2点:使用直後と変わらず肌が十分うるおっていると感じた場合。
1点:使用直後と比べてやや肌のうるおいが足りないと感じた場合。
0点:使用直後と比べて明らかに肌のうるおいが足りないと感じた場合。
(3) Persistence of moisturizing effect 20 females (21 to 35 years old) are panelists, and after washing their face, using a skin cosmetic (about 2 g), the skin moisture after 2 hours is determined as follows. Then, the average value of 20 people was obtained, and the average value of 1.5 points or more was evaluated as a cosmetic having a good moisturizing effect.
2 points: When the skin feels sufficiently moistened just after use.
1 point: When feeling that the moisture of the skin is slightly insufficient compared with immediately after use.
0 point: When it feels that the moisture of the skin is clearly insufficient compared with immediately after use.

(4)肌荒れ改善効果
肌荒れを生じている10名の女性(24才〜34才)をパネラーとし、皮膚化粧料を一日2回ずつ連日2週間にわたって使用した時の肌の状態について官能検査し、下記のように判定し、10名の平均値を求めて、平均値1.5点以上を肌荒れ改善効果のある化粧料であると評価した。
2点:肌荒れが明らかに治ってきたと感じた場合。
1点:肌荒れがやや治ってきたと感じた場合。
0点:肌荒れ改善効果が全く見られないと感じた場合。
(4) Rough skin improvement effect 10 females (24 to 34 years old) with rough skin are used as panelists, and the skin condition when skin cosmetics are used twice a day for 2 weeks is examined. The average value of 10 persons was calculated | required as follows, and average value 1.5 point or more was evaluated as the cosmetics with a rough skin improvement effect.
2 points: When it is felt that rough skin has been cured.
1 point: When it feels that the rough skin has been cured somewhat.
0 point: When it feels that the rough skin improvement effect is not seen at all.

(5)しわ抑制効果
20名の女性(21才〜35才)をパネラーとし、皮膚化粧料を一日2回ずつ連日2週間にわたって使用した時の肌の状態について官能検査し、下記のように判定し、20名の平均値を求めて、平均値1.5点以上をしわ抑制効果に優れた化粧料であると評価した。
2点:しわが明らかに目立たなくなったと感じた場合。
1点:しわがやや目立たなくなったと感じた場合。
0点:しわ抑制効果が全く無いと感じた場合。
(5) Wrinkle-suppressing effect 20 females (21-35 years old) are panelists, and the skin condition when skin cosmetics are used twice a day for 2 weeks is examined. The average value of 20 persons was determined, and an average value of 1.5 points or more was evaluated as a cosmetic excellent in wrinkle suppression effect.
2 points: When wrinkles are clearly inconspicuous.
1 point: When wrinkles are slightly inconspicuous.
0 point: When it feels that there is no wrinkle suppression effect.

(6)肌のはり
20名の女性(21才〜35才)をパネラーとし、皮膚化粧料を一日2回ずつ連日2週間にわたって使用した時の肌の状態について官能検査し、下記のように判定し、20名の平均値を求めて、平均値1.5点以上を肌にはりを与える効果のある化粧料であると評価した。
2点:明らかに肌にはりがでたと感じた場合。
1点:やや肌にはりがでたと感じた場合。
0点:肌にはりがでないと感じた場合。
(6) Skin tension 20 females (21 to 35 years old) are panelists, and the skin condition when skin cosmetics are used twice a day for 2 weeks is examined. The average value of 20 persons was determined, and an average value of 1.5 points or more was evaluated as a cosmetic having an effect of applying a skin tone.
2 points: When the skin is clearly felt.
1 point: If you feel that your skin is slightly bitten.
0 points: When the skin feels non-sticky.

(7)経時安定性
化粧料を透明ガラス容器に密封して0℃、25℃、40℃で3ヶ月間保存し、その外観を観察して、下に示す3段階で評価した。
○:安定性良好(いずれの温度においても外観の変化がない。)
△:安定性やや不良(いずれかの温度において若干の外観の変化があり、沈殿を生じるまたは若干着色を生じる。)
×:安定性不良(いずれかの温度において外観の変化があり、沈殿を生じるまたは分離する。もしくは着色が著しい。)
(7) Stability over time The cosmetic was sealed in a transparent glass container and stored at 0 ° C., 25 ° C. and 40 ° C. for 3 months. The appearance was observed and evaluated in the following three stages.
○: Good stability (no change in appearance at any temperature)
Δ: Slightly inferior (slight appearance change at any temperature, resulting in precipitation or slight coloration)
X: poor stability (change in appearance at any temperature, resulting in precipitation or separation, or significant coloration)

実施例1〜3より、本発明の成分を用いた化粧水はいずれも使用時の感触が良好で使用後もべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れるとともに肌にはりを与え、経時安定性にも優れていた。一方、比較例1、2では十分な性能が得られていなかった。つまり、比較例1では(a)成分が配合されていないことから、保湿効果の持続性、肌荒れ改善効果、しわ抑制効果が弱くなっており、比較例2では(b)成分が配合されていないことから使用時の感触、肌荒れ改善効果、しわ抑制効果が弱くなるとともに肌にはりを与える効果が弱くなったと考えられる。   From Examples 1 to 3, the lotions using the ingredients of the present invention all have a good feel during use and are not sticky after use, have excellent moisturizing effects, have excellent skin roughness improvement effects, and wrinkle suppression effects. It gave skin elasticity and was excellent in stability over time. On the other hand, in Comparative Examples 1 and 2, sufficient performance was not obtained. That is, since the component (a) is not blended in Comparative Example 1, the durability of the moisturizing effect, the rough skin improving effect, and the wrinkle suppressing effect are weakened. In Comparative Example 2, the component (b) is not blended. From this, it is considered that the touch, the rough skin improving effect, and the wrinkle suppressing effect are weakened and the effect of giving the skin is weakened.

実施例4〜6、比較例3、4
表3に示す水中油型乳液である皮膚化粧料を調製し、実施例1〜3と同様の方法により評価を行なった。但し、共通添加成分としては、表4に示す14成分を使用した。なお、表3中に表される各用語の意義は、前述の表1と同様である。
Examples 4 to 6, Comparative Examples 3 and 4
Skin cosmetics that are oil-in-water emulsions shown in Table 3 were prepared and evaluated in the same manner as in Examples 1 to 3. However, 14 components shown in Table 4 were used as common additive components. In addition, the meaning of each term represented in Table 3 is the same as that of the above-mentioned Table 1.

結果を表3に示す。   The results are shown in Table 3.

Figure 2006151834
Figure 2006151834

注1;「Lipidure−HM」(日本油脂(株)製)「MPC100重量%の構成で重量平均分子量約8万のポリマー40重量%含有水溶液」
注2;「Lipidure−PMB」(日本油脂(株)製)「MPC80重量%、メタクリル酸ブチル20重量%の構成比で重量平均分子量約60万のポリマー5重量%含有水溶液」
注3;「POTURACA EXTRACT」(バイオランド社製Lot.NMP-L-150603)
注4;「POTURACA EXTRACT」(バイオランド社製Lot.NMP-L-202223)
注5;「グリチリチンK2」(丸善製薬(株))
注6;「アラントイン」(川研ファインケミカル(株))
Note 1: “Lipidure-HM” (manufactured by NOF Corporation) “Aqueous solution containing 40% by weight of polymer having a weight average molecular weight of about 80,000 with MPC of 100% by weight”
Note 2: “Lipidure-PMB” (manufactured by NOF Corporation) “Aqueous solution containing 5% by weight of polymer having a weight average molecular weight of about 600,000 with a composition ratio of 80% by weight of MPC and 20% by weight of butyl methacrylate”
Note 3: “POTURACA EXTRACT” (Bioland Lot.NMP-L-150603)
Note 4: “POTURACA EXTRACT” (Bioland Lot.NMP-L-202223)
Note 5: “Glychiritin K2” (Maruzen Pharmaceutical Co., Ltd.)
Note 6: “Allantoin” (Kawaken Fine Chemical Co., Ltd.)

Figure 2006151834
Figure 2006151834

実施例4〜6より、本発明の成分を用いた乳液はいずれも使用時の感触が良好で使用後もべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れるとともに肌にはりを与え、経時安定性にも優れていた。一方、比較例3、4では十分な性能が得られていない。つまり、比較例3では(a)成分が配合されていないことから、保湿効果の持続性、肌荒れ改善効果、しわ抑制効果が弱くなっており、比較例4では(b)成分が本発明の範囲をより少なく配合されていることから肌荒れ改善効果、しわ抑制効果、肌のはりが弱くなっていると考えられる。   From Examples 4 to 6, all the emulsions using the ingredients of the present invention have a good feel during use and are not sticky after use, have excellent moisturizing effects, have excellent skin roughness improvement effects, wrinkle suppression effects, and skin. It gave a burr and was excellent in stability over time. On the other hand, in Comparative Examples 3 and 4, sufficient performance is not obtained. That is, since the component (a) is not blended in Comparative Example 3, the sustainability of the moisturizing effect, the rough skin improving effect, and the wrinkle suppressing effect are weakened. In Comparative Example 4, the component (b) is within the scope of the present invention. It is thought that the skin roughening effect, the wrinkle suppression effect, and the skin elasticity are weakened.

実施例7、8
表5に示す水中油型クリームである皮膚化粧料を調製し、評価項目(1)〜(6)は実施例1〜3の方法により、そして評価項目(7)の経時安定性については下記の検査により評価を行なった。但し、共通添加成分として表6に示す13成分を使用した。なお、表5中に表される各用語の意義は、前述の表1と同様である。
Examples 7 and 8
Skin cosmetics that are oil-in-water creams shown in Table 5 were prepared. Evaluation items (1) to (6) were carried out by the methods of Examples 1 to 3, and the stability over time of evaluation item (7) was as follows. Evaluation was made by inspection. However, 13 components shown in Table 6 were used as common additive components. In addition, the meaning of each term represented in Table 5 is the same as that of the above-mentioned Table 1.

結果を表5に示す。   The results are shown in Table 5.

Figure 2006151834
Figure 2006151834

注1;「Lipidure−HM」(日本油脂(株)製)「MPC100重量%の構成で重量平均分子量約8万のポリマー40重量%含有水溶液」
注2;「Lipidure−PMB」(日本油脂(株)製)「MPC80重量%、メタクリル酸ブチル20重量%の構成比で重量平均分子量約60万のポリマー5重量%含有水溶液」
注3;「POTURACA EXTRACT」(バイオランド社製Lot.NMP-L-150603)
注4;「POTURACA EXTRACT」(バイオランド社製Lot.NMP-L-202223)
注5;「グリチリチンK2」(丸善製薬(株))
注6;「アラントイン」(川研ファインケミカル(株))
注7;「シーオーグレチノール」(丸善製薬(株))
Note 1: “Lipidure-HM” (manufactured by NOF Corporation) “Aqueous solution containing 40% by weight of polymer having a weight average molecular weight of about 80,000 with MPC of 100% by weight”
Note 2: “Lipidure-PMB” (manufactured by NOF Corporation) “Aqueous solution containing 5% by weight of polymer having a weight average molecular weight of about 600,000 with a composition ratio of 80% by weight of MPC and 20% by weight of butyl methacrylate”
Note 3: “POTURACA EXTRACT” (Bioland Lot.NMP-L-150603)
Note 4: “POTURACA EXTRACT” (Bioland Lot.NMP-L-202223)
Note 5: “Glychiritin K2” (Maruzen Pharmaceutical Co., Ltd.)
Note 6: “Allantoin” (Kawaken Fine Chemical Co., Ltd.)
Note 7: “Sea Augretinol” (Maruzen Pharmaceutical Co., Ltd.)

Figure 2006151834
Figure 2006151834

(7)経時安定性
化粧料を透明ガラス容器に密封して−5℃、25℃、45℃で1ヶ月間保存したときの状態を調査し、下に示す3段階で評価した。
○:安定性良好(いずれの温度においても外観の変化がなくブツ等も生じない。)
△:安定性やや不良(いずれかの温度において僅かに沈殿を生じるか僅かに分離が見られる。または僅かにブツ、ダマを生じている。)
×:安定性不良(いずれかの温度において明らかに沈殿を生じるか分離する。)
(7) Stability over time The state when the cosmetic was sealed in a transparent glass container and stored at −5 ° C., 25 ° C., and 45 ° C. for 1 month was evaluated and evaluated in the following three stages.
○: Stability is good (no change in appearance at any temperature and no flickering etc.)
Δ: Slightly poor (slight precipitation or slight separation at any temperature, or slight lumps and lumps)
X: poor stability (clearly precipitate or separate at any temperature)

実施例7、8より、本発明のクリームはいずれも使用時の感触が良好で使用後もべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れるとともに肌にはりを与え、経時安定性にも優れていた。   From Examples 7 and 8, the cream of the present invention has a good feel during use and is not sticky after use, has excellent moisturizing effect, has excellent skin roughness improvement effect, wrinkle suppression effect and gives skin elasticity. The stability over time was also excellent.

実施例9、10
表5に示す油中水型クリームである皮膚化粧料を調製し、実施例7、8に示す評価方法により評価を行なった。但し、共通添加成分として表7に示す11成分を使用した。
Examples 9, 10
Skin cosmetics that are water-in-oil creams shown in Table 5 were prepared and evaluated by the evaluation methods shown in Examples 7 and 8. However, 11 components shown in Table 7 were used as common additive components.

Figure 2006151834
Figure 2006151834

実施例9、10の結果から、本発明のクリームはいずれも使用時の感触が良好で使用後もべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れるとともに肌にはりを与え、経時安定性にも優れていた。   From the results of Examples 9 and 10, all of the creams of the present invention have a good feel during use and are not sticky after use, have excellent moisturizing effect, have excellent skin roughness improvement effect, wrinkle suppression effect and are applied to the skin. And stability over time was also excellent.

以上述べたとおり、本発明の皮膚化粧料は、使用時の感触が良好で使用後もべたつかず、保湿効果の持続性に優れ、肌荒れ改善効果、しわ抑制効果に優れるとともに肌にはりを与え、経時安定性にも優れた皮膚化粧料であり、欺界に与える影響は多大である。   As described above, the skin cosmetic of the present invention has a good feel during use and is not sticky after use, has excellent moisturizing effect, has excellent skin roughness improvement effect, wrinkle suppression effect and gives a skin tone, It is a skin cosmetic excellent in stability over time, and has a great influence on the deception world.

Claims (2)

(a)成分として、式(I)で示される2−(メタ)アクリロイルオキシエチルホスホリルコリンに基づく構成単位と、(メタ)アクリル酸アルキルエステルに基づく構成単位とを100/0〜10/90のモル比で含み、両構成単位の合計重量%が60〜100%である共重合体0.005〜10重量%、(b)成分として、スベリヒユ抽出エキスを乾燥重量として0.0005〜2重量%含有することを特徴とする皮膚化粧料。
Figure 2006151834
(式中R1は水素原子またはメチル基を、R、R及びRはそれぞれ炭素数1〜8のアルキル基、nは2〜4の整数を示す。)
(A) 100/0 to 10/90 moles of a structural unit based on 2- (meth) acryloyloxyethyl phosphorylcholine represented by formula (I) and a structural unit based on (meth) acrylic acid alkyl ester as component (a) The copolymer contains 0.005 to 10% by weight of the total weight% of both constituent units in a ratio of 60 to 100%, and contains 0.0005 to 2% by weight of the purslane extract as a dry weight as the component (b). A skin cosmetic characterized by.
Figure 2006151834
(Wherein R 1 represents a hydrogen atom or a methyl group, R 2 , R 3 and R 4 each represents an alkyl group having 1 to 8 carbon atoms, and n represents an integer of 2 to 4)
さらに、(c)成分として、抗炎症剤を0.001〜10重量%含有することを特徴とする請求項1記載の皮膚化粧料。   Furthermore, 0.001-10 weight% of anti-inflammatory agents are contained as (c) component, The skin cosmetics of Claim 1 characterized by the above-mentioned.
JP2004341305A 2004-11-25 2004-11-25 Skin cosmetics Active JP5311704B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2004341305A JP5311704B2 (en) 2004-11-25 2004-11-25 Skin cosmetics
KR1020050107423A KR100698356B1 (en) 2004-11-25 2005-11-10 Skin cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004341305A JP5311704B2 (en) 2004-11-25 2004-11-25 Skin cosmetics

Publications (2)

Publication Number Publication Date
JP2006151834A true JP2006151834A (en) 2006-06-15
JP5311704B2 JP5311704B2 (en) 2013-10-09

Family

ID=36630551

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004341305A Active JP5311704B2 (en) 2004-11-25 2004-11-25 Skin cosmetics

Country Status (2)

Country Link
JP (1) JP5311704B2 (en)
KR (1) KR100698356B1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010043018A (en) * 2008-08-12 2010-02-25 Sunstar Inc Skin care composition
JP2012184182A (en) * 2011-03-04 2012-09-27 Nof Corp Liposome for cosmetic and cosmetic
KR20180027160A (en) * 2016-09-06 2018-03-14 주식회사 피코스텍 Composition for inhibiting or improving seborrhea or seborrheic eczema comprising an extract of Portulaca grandiflora Hooker
JP2018177721A (en) * 2017-04-17 2018-11-15 日油株式会社 Aqueous cosmetic
JP2018193318A (en) * 2017-05-16 2018-12-06 小林製薬株式会社 Emulsion composition
JPWO2019107440A1 (en) * 2017-11-30 2021-01-14 株式会社 資生堂 Cholesterol synthesis promoter

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102178890B1 (en) * 2014-11-06 2020-11-16 주식회사 엘지생활건강 Composition for promoting synthesis of hyaluronic acid comprising Portulacae Herba extracts and the use thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63192705A (en) 1987-02-05 1988-08-10 Shiseido Co Ltd External agent for skin
JPH1045626A (en) * 1996-07-31 1998-02-17 Nof Corp Base for preparation for external use for skin and component of the base
JP2001064151A (en) 1999-06-23 2001-03-13 Nof Corp Skin cosmetic
JP2002060332A (en) 2000-08-17 2002-02-26 Nof Corp Cosmetic for skin
WO2004060289A2 (en) * 2002-12-31 2004-07-22 Avon Products, Inc. Use of purslane to treat facial wrinkles

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63192705A (en) 1987-02-05 1988-08-10 Shiseido Co Ltd External agent for skin
JPH1045626A (en) * 1996-07-31 1998-02-17 Nof Corp Base for preparation for external use for skin and component of the base
JP2001064151A (en) 1999-06-23 2001-03-13 Nof Corp Skin cosmetic
JP2002060332A (en) 2000-08-17 2002-02-26 Nof Corp Cosmetic for skin
WO2004060289A2 (en) * 2002-12-31 2004-07-22 Avon Products, Inc. Use of purslane to treat facial wrinkles

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CSNC200801335025; '新原料紹介' FRAGRANCE JOURNAL Vol.28, No.8 第28巻, 津野田 勲 ▲C▼フレグランス ジャーナル社 *
CSNC200801339026; 土田 衛 Mamoru Tsuchida: '特集 香粧品の新原料・新技術' FRAGRANCE JOURNAL Vol.28, No.12 第28巻, 津野田 勲 ▲C▼フレグランス ジャーナル社 *
JPN6010016620; 土田 衛 Mamoru Tsuchida: '特集 香粧品の新原料・新技術' FRAGRANCE JOURNAL Vol.28, No.12 第28巻, 津野田 勲 ▲C▼フレグランス ジャーナル社 *
JPN6010016621; '新原料紹介' FRAGRANCE JOURNAL Vol.28, No.8 第28巻, 津野田 勲 ▲C▼フレグランス ジャーナル社 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010043018A (en) * 2008-08-12 2010-02-25 Sunstar Inc Skin care composition
JP2012184182A (en) * 2011-03-04 2012-09-27 Nof Corp Liposome for cosmetic and cosmetic
KR20180027160A (en) * 2016-09-06 2018-03-14 주식회사 피코스텍 Composition for inhibiting or improving seborrhea or seborrheic eczema comprising an extract of Portulaca grandiflora Hooker
KR101865542B1 (en) * 2016-09-06 2018-06-08 주식회사 피코스텍 Composition for inhibiting or improving seborrhea or seborrheic eczema comprising an extract of Portulaca grandiflora Hooker
JP2018177721A (en) * 2017-04-17 2018-11-15 日油株式会社 Aqueous cosmetic
JP2018193318A (en) * 2017-05-16 2018-12-06 小林製薬株式会社 Emulsion composition
JP7312527B2 (en) 2017-05-16 2023-07-21 小林製薬株式会社 emulsion composition
JPWO2019107440A1 (en) * 2017-11-30 2021-01-14 株式会社 資生堂 Cholesterol synthesis promoter
JP7471085B2 (en) 2017-11-30 2024-04-19 株式会社 資生堂 Cholesterol synthesis promoter

Also Published As

Publication number Publication date
KR20060058630A (en) 2006-05-30
JP5311704B2 (en) 2013-10-09
KR100698356B1 (en) 2007-03-23

Similar Documents

Publication Publication Date Title
JP4670366B2 (en) Skin cosmetics
JP7307835B2 (en) aqueous composition
KR100698356B1 (en) Skin cosmetics
US20060093689A1 (en) Skin cosmetics
JP2005306831A (en) Skin care preparation for external use
JPH10101540A (en) Combination of deodorizing compound based on wool wax acid, partial glyceride, and aryl compound
JP7446743B2 (en) Topical composition comprising Pichia anomara and retinol
JP4332458B2 (en) Skin cosmetics
JP4126819B2 (en) Skin cosmetics
KR20200026112A (en) Topical compositions comprising pichia anomala and n-acetyl glucosamine
JP5494142B2 (en) Topical skin preparation
CN116583257A (en) Compositions comprising (bio) -alkanediols
JP2008308462A (en) Skin care composition
JP2015218135A (en) External preparation for skin
JP2013129638A (en) Cosmetic material
JP2000344697A (en) Long-chain branched alcohol and cosmetic and external preparation produced by using the alcohol
JP5494141B2 (en) Topical skin preparation
JP5382969B2 (en) Arginase activity promoter and skin external preparation containing the same
US20130065871A1 (en) Emulsion composition
JP2020015699A (en) Skin cosmetics
JP4529402B2 (en) Skin cosmetics
JP2001316238A (en) Skin cosmetic
JP4839502B2 (en) External preparation for skin containing arginase activity promoter
JP2022166655A (en) Skin cosmetic
JP2002060332A (en) Cosmetic for skin

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071121

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100406

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100720

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20101111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130322

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130702

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5311704

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250